MetLife Investment Management’s Biohaven BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $770K | Buy |
54,560
+3,499
| +7% | +$49.4K | ﹤0.01% | 1453 |
|
2025
Q1 | $1.23M | Sell |
51,061
-676
| -1% | -$16.3K | 0.01% | 1264 |
|
2024
Q4 | $1.93M | Buy |
51,737
+8,248
| +19% | +$308K | 0.01% | 1065 |
|
2024
Q3 | $2.17M | Hold |
43,489
| – | – | 0.01% | 973 |
|
2024
Q2 | $1.51M | Buy |
43,489
+8,301
| +24% | +$288K | 0.01% | 1117 |
|
2024
Q1 | $1.92M | Sell |
35,188
-836
| -2% | -$45.7K | 0.01% | 968 |
|
2023
Q4 | $1.54M | Buy |
36,024
+4,252
| +13% | +$182K | 0.01% | 1079 |
|
2023
Q3 | $826K | Hold |
31,772
| – | – | 0.01% | 1345 |
|
2023
Q2 | $760K | Sell |
31,772
-2,067
| -6% | -$49.4K | 0.01% | 1428 |
|
2023
Q1 | $462K | Hold |
33,839
| – | – | ﹤0.01% | 1693 |
|
2022
Q4 | $470K | Buy |
+33,839
| New | +$470K | ﹤0.01% | 1683 |
|